The Latest Analyst Ratings for Globus Medical
Portfolio Pulse from Benzinga Insights
Globus Medical (NYSE:GMED) has received one somewhat bullish and four indifferent analyst ratings in the last quarter. The average price target is $67.6, indicating an upside from the current price of $54.085. The average price target has increased by 0.9% over the past month.
September 05, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Globus Medical has received mostly indifferent analyst ratings, with an average price target indicating potential upside.
The indifferent analyst ratings suggest uncertainty about the company's performance. However, the average price target, which is higher than the current price, indicates potential for stock price increase. The 0.9% increase in the average price target over the past month also suggests growing confidence in the company's potential.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100